6:06 PM
Nov 08, 2007
 |  BC Extra  |  Clinical News

Repligen reports RG2417 results

RGEN said treatment with oral RG2417 led to a significant improvement in Montgomery-Asberg Depression Rating Scale (MADRS) score,...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >